Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.4K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.4K
Hematopoiesis01:21

Hematopoiesis

6.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
6.9K
Production of Formed Elements01:34

Production of Formed Elements

2.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronopol and benzisothiazolinone exhibit synergistic toxicity with enhanced cell stress responses exceeding the impacts of individual compounds.

Environmental toxicology and pharmacology·2026
Same author

Synergistic cytotoxicity of benzalkonium chloride and didecyldimethylammonium chloride mixtures revealed by stress granule formation.

Toxicology·2026
Same author

Effect of infection temperature on infectivity and host response of human coronavirus OC43.

Virology·2026
Same author

Radiation Therapy Documentation Deficiencies in Cancer Survivorship Documents.

Practical radiation oncology·2026
Same author

Tetramethylthiuram disulfide induces stress granules and DNA damage through oxidative stress in human lung epithelial cells.

Animal cells and systems·2026
Same author

Experimental evaluation of Salmonella Choleraesuis pathogenicity and porcine reproductive and respiratory syndrome virus synergy in weaned pigs.

Porcine health management·2026
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

Isolation of Murine Embryonic Hemogenic Endothelial Cells
08:56

Isolation of Murine Embryonic Hemogenic Endothelial Cells

Published on: June 17, 2016

11.7K

Mouse ES cell-derived hematopoietic progenitor cells.

Eun-Mi Kim1, Gohar Manzar, Nicholas Zavazava

  • 1Department of Internal Medicine, Division of Immunology, University of Iowa, Iowa City, IA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|June 13, 2013
PubMed
Summary
This summary is machine-generated.

Future stem cell therapies require understanding pluripotent stem cells like embryonic stem (ES) and induced pluripotent stem (IPS) cells. Research is needed to determine the therapeutic potential and engraftment capabilities of these cells for clinical applications.

More Related Videos

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

8.3K
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 24, 2007

13.5K

Related Experiment Videos

Last Updated: Oct 13, 2025

Isolation of Murine Embryonic Hemogenic Endothelial Cells
08:56

Isolation of Murine Embryonic Hemogenic Endothelial Cells

Published on: June 17, 2016

11.7K
Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

8.3K
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 24, 2007

13.5K

Area of Science:

  • Stem cell biology and regenerative medicine.

Background:

  • Pluripotent stem cells, including embryonic stem (ES) cells and induced pluripotent stem (IPS) cells, offer promise for patient-tailored therapies.
  • Current protocols for deriving therapeutic-grade progenitor cells from pluripotent stem cells are underdeveloped.
  • The clinical potential of these derived cells compared to adult progenitor cells remains largely unknown.

Purpose of the Study:

  • To review the current understanding of murine hematopoietic progenitor cells derived from mouse ES cells.
  • To highlight the critical need for research into the engraftment potential and multi-lineage engraftment capabilities of pluripotent stem cell-derived progenitors in vivo.
  • To discuss factors influencing the generation and behavior of these cells, such as cell surface markers, bone marrow niches, and culture conditions.

Main Methods:

  • Review of existing literature on mouse ES cell-derived hematopoietic progenitor cells.
  • Discussion of cell surface markers, homing patterns, and engraftment potential.
  • Analysis of factors influencing progenitor cell generation, including cell lines and culture media.

Main Results:

  • Mouse ES cell-derived progenitor cells are a focus of research for potential therapeutic applications.
  • Engraftment potential and multi-lineage differentiation are key determinants for clinical use.
  • Variability in cell lines and culture conditions impacts cell maturation and homing.

Conclusions:

  • Further research is essential to establish robust protocols for generating clinical-grade progenitor cells from pluripotent stem cells.
  • Understanding the in vivo behavior, particularly engraftment and homing, is crucial before clinical translation.
  • Advances in understanding bone marrow niches and cell culture methods will improve stem cell transplantation therapies.